Prenetics Global Limited

NASDAQ: PRE · Real-Time Price · USD
5.30
0.07 (1.34%)
At close: May 02, 2025, 12:40 PM
1.34%
Bid 5.21
Market Cap 64.75M
Revenue (ttm) 25.56M
Net Income (ttm) -49.01M
EPS (ttm) -3.73
PE Ratio (ttm) -1.42
Forward PE -7.37
Analyst Buy
Ask 5.48
Volume 4,001
Avg. Volume (20D) 8,609
Open 5.45
Previous Close 5.23
Day's Range 5.03 - 5.50
52-Week Range 3.10 - 6.99
Beta -0.21

About PRE

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer ...

Sector Healthcare
IPO Date Jul 16, 2021
Employees 320
Stock Exchange NASDAQ
Ticker Symbol PRE
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for PRE stock is "Buy." The 12-month stock price forecast is $9, which is an increase of 69.81% from the latest price.

Stock Forecasts
6 months ago
+19.13%
Prenetics Global shares are trading higher followi... Unlock content with Pro Subscription
8 months ago
+5.47%
Prenetics Global Limited shares are trading higher after the company announced the acquisition of Europa Sports Partners and its subsidiary, Hubmatrix.